ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA
Public ClinicalTrials.gov record NCT03891875. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-Masked, Placebo-Controlled Clinical Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Elamipretide in Subjects With Age-Related Macular Degeneration With Non-central Geographic Atrophy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A randomized, double-masked, placebo-controlled study to evaluate the safety, efficacy and pharmacokinetics of elamipretide in subjects with Age-Related Macular Degeneration with non-central Geographic Atrophy.
Study identification
- NCT ID
- NCT03891875
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 176 participants
Conditions and interventions
Conditions
Interventions
- Subcutaneous elamipretide through the elamipretide delivery system Combination Product
- Subcutaneos placebo through the elamipretide delivery system Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 55 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 27, 2019 (Actual)
- Primary completion
- Feb 22, 2022 (Actual)
- Completion
- Apr 14, 2022 (Actual)
- Last update posted
- Jul 12, 2024
2019 – 2022
United States locations
- U.S. sites
- 37
- U.S. states
- 17
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Associated Retina Consultants, Ltd. | Peoria | Arizona | 85381 | — |
| Retinal Research Institute, LLC | Phoenix | Arizona | 85014 | — |
| Arizona Retina & Vitreous Consultants | Phoenix | Arizona | 85021 | — |
| Retinal Research Institute, LLC | Phoenix | Arizona | 85053 | — |
| Global Retina Institute | Scottsdale | Arizona | 85254 | — |
| California Retina Consultants | Bakersfield | California | 93309 | — |
| Retina-Vitreous Associates Medical Group | Beverly Hills | California | 90211 | — |
| Retina Institute of California Medical Group | Palm Desert | California | 92260 | — |
| California Retina Consultants | Santa Barbara | California | 93103 | — |
| California Retina Consultants | Santa Maria | California | 93454 | — |
| Bascom Palmer Eye Institute | Miami | Florida | 33136 | — |
| MedEye Associates | Miami | Florida | 33143 | — |
| Bascom Palmer Eye Institute | Palm Beach Gardens | Florida | 33418 | — |
| Center for Retina and Macular Disease | Winter Haven | Florida | 33880 | — |
| Southeast Retina Center, PC | Augusta | Georgia | 30909 | — |
| The Retina Care Center | Baltimore | Maryland | 21209 | — |
| Cumberland valley retina consultants | Hagerstown | Maryland | 21740 | — |
| Ophthalmic Consultants of Boston | Boston | Massachusetts | 02114 | — |
| New England Retina Consultants | Springfield | Massachusetts | 01107 | — |
| Specialty Eye Institute | Jackson | Michigan | 49202 | — |
| Retina Center of New Jersey LLC | Bloomfield | New Jersey | 07003 | — |
| New Jersey Retina | Teaneck | New Jersey | 07666 | — |
| Retina Associates of Western New York | Rochester | New York | 14620 | — |
| Duke Eye center | Durham | North Carolina | 27705 | — |
| Sterling Research Group | Cincinnati | Ohio | 45202 | — |
| Oklahoma University Health Sciences Center | Oklahoma City | Oklahoma | 73104 | — |
| Retina Northwest, P.C | Portland | Oregon | 97221 | — |
| Black Hills Regional Eye Institute | Rapid City | South Dakota | 57701 | — |
| Tennessee Retina | Nashville | Tennessee | 37203 | — |
| Retina Research Institute of Texas | Abilene | Texas | 79606 | — |
| Retina Research Center, PLLC | Austin | Texas | 78705 | — |
| Ophthalmology Associates | Fort Worth | Texas | 76102 | — |
| Texas Retina Associates | Fort Worth | Texas | 76104 | — |
| Retina Consultants of Houston, PA | Houston | Texas | 77030 | — |
| Retina Consultants of Houston | Katy | Texas | 77494 | — |
| Valley Retina Institute, PA | McAllen | Texas | 78503 | — |
| University of Virginia, Department of Ophthalmology | Charlottesville | Virginia | 22903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03891875, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 12, 2024 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03891875 live on ClinicalTrials.gov.